Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord.
about
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injuryHuman neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse modelCellular treatments for spinal cord injury: the time is right for clinical trialsCurrent and future medical therapeutic strategies for the functional repair of spinal cord injuryPotential role of stem cells in severe spinal cord injury: current perspectives and clinical dataIntrinsic migratory properties of cultured Schwann cells based on single-cell migration assayChronic spinal injury repair by olfactory bulb ensheathing glia and feasibility for autologous therapyTissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion.Dose and chemical modification considerations for continuous cyclic AMP analog delivery to the injured CNSOlfactory ensheathing cell transplantation for spinal cord injury: An 18-year bibliometric analysis based on the Web of ScienceSuspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord.Differing Schwann cells and olfactory ensheathing cells behaviors, from interacting with astrocyte, produce similar improvements in contused rat spinal cord's motor function.Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells.Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury.A systematic review of cellular transplantation therapies for spinal cord injury.NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injuryProinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury.Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury.Acute Putrescine Supplementation with Schwann Cell Implantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injured RatsDissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants.Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stagesClinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy.Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokinesFabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.The Utility of 3D Ultramicroscopy for Evaluating Cellular Therapies After Spinal Cord Injury.Cell transplantation: toward cell therapy.Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy.Article Commentary: Regenerative Medicine: An Analysis of Cell Transplantation's Impact.Resection of glial scar following spinal cord injury.Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord.Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.Transplantation of neural progenitor cells in chronic spinal cord injury.Novel strategies in brachial plexus repair after traumatic avulsion.Animal models of axon regeneration after spinal cord injury.Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?Cell transplantation therapy for spinal cord injury.Toward defining the regenerative potential of olfactory mucosa: establishment of Schwann cell-free adult canine olfactory ensheathing cell preparations suitable for transplantation.Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury.Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury.
P2860
Q21089854-28EEC182-0385-45D0-B9FA-1E44A34B10AEQ21136171-A070E03A-7FCD-4837-8BE8-9719C636B177Q24630772-34B3EC95-1449-4E59-A787-34149C1C6C7BQ26824854-434B87A1-52F3-4060-A99C-442ABF97B89FQ26996685-9537E0EE-E6AA-4B1D-9249-509B2DCE849DQ27329703-96CE681D-0A6A-4893-89C0-68611FB8308BQ30494658-CD1D34D3-C32C-47B4-B492-496AF61F505BQ30558579-56CC696E-BD1B-4422-8E69-FF22A09521F0Q33766778-731577D3-5FD1-4000-B778-01ACBA3C4882Q33937082-387CB618-A71E-4EC3-A3F4-68F1D17F0FDBQ34147902-BE41C12C-28EA-40F5-A20F-6AFC4AB5DF11Q34190964-F8AC2347-56D0-4F75-9069-88B70BDDFD26Q34338454-4BA31224-9601-4A8A-93C7-0031F8A23F06Q35022647-2CE0681A-BA9A-4B1E-8596-1AB839729FC3Q35071889-FBF37244-21F5-425F-8A66-429B1B937EA5Q35127777-AA166E71-7BA3-4278-BC3B-B187EB415AA7Q35200151-B27954A1-A9B8-4257-A731-62FD7E75EF37Q35249097-1A0D4F35-8C0C-416E-8467-0ACBD5069F2CQ35295364-991BF95F-0A8B-43CF-AF73-F4B887D3AD04Q36208953-71285E1B-9F5A-49BC-9783-B62718A90E45Q36321615-5F53647A-F0A6-4795-84DB-5AF7CB857779Q36390877-F294094F-0222-4DA3-89C2-FB5A2674DEC2Q36415316-1D79EA48-E38C-467D-9C06-FE7EE5FDC639Q36457510-82E8F262-CBC5-491E-BFCE-59188D054FE9Q36464568-18845447-3CD4-4C75-B8CC-B65A46A79868Q36646179-49BF7F54-5F96-4DCA-B3B6-FA7E9936BFAFQ36687136-45FDE4DF-27CE-48D8-B948-D328E20F9CA4Q36762820-444F3670-767D-4A7F-BE53-DD5555009408Q37003823-6DEED9C1-75D5-45BA-8979-3E84662275B1Q37227963-35CB4EA5-7B96-49D5-BBED-F9D75915EBC9Q37476168-5F8ED836-0C19-4A00-96F9-FC0E0AC0ED9DQ37526111-67CFDA6A-1652-4E11-9647-0BB9702261F7Q37619428-F145E200-6965-4C97-9226-0E6B48CFFAACQ37803399-54B2FB73-1106-4071-902F-9D616DCD6962Q38124778-CCA20A5F-444E-48A7-9504-B7C2A3BFB52EQ38809907-A3725E0C-1E0B-421F-99D5-6A52CB137D53Q39261219-3296D90C-2216-4FCA-B024-1AF758DC17A6Q39548069-20A2561A-ED7D-469A-BD63-6CB446F03C8AQ40125092-4698E1E3-FDFF-416D-8D71-A46BAF6DF1E8Q41488702-6A40CC21-33DC-4D70-9409-A5D2B646502A
P2860
Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Survival, integration, and axo ...... onically contused spinal cord.
@en
Survival, integration, and axo ...... onically contused spinal cord.
@nl
type
label
Survival, integration, and axo ...... onically contused spinal cord.
@en
Survival, integration, and axo ...... onically contused spinal cord.
@nl
prefLabel
Survival, integration, and axo ...... onically contused spinal cord.
@en
Survival, integration, and axo ...... onically contused spinal cord.
@nl
P2093
P2860
P1433
P1476
Survival, integration, and axo ...... onically contused spinal cord.
@en
P2093
Andrade CM
Barakat DJ
Gaglani SM
Neravetla SR
Pressman Y
Sanchez AR
P2860
P304
P356
10.3727/000000005783983106
P577
2005-01-01T00:00:00Z